Actinium Pharmaceuticals, Inc. (ATNM)

1.575 0.00 (0.00%) USD  |  NYAM  |  Dec 24, 12:59
1.575 0.00 (0.00%) After-Hours: 13:52
More

Actinium Pharmaceuticals SG&A Expense (TTM): 15.79M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Arcus Biosciences, Inc. 112.00M
Apyx Medical Corp. 22.16M
AbbVie, Inc. 13.97B
Karyopharm Therapeutics, Inc. 109.63M
NovaBay Pharmaceuticals, Inc. 8.584M